Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway
Dipeptidyl peptidase III (DPP III) is associated with cancer progression via interaction with KEAP1, leading to upregulation of the KEAP1-NRF2 oxidative stress pathway. Numerous DPP III mutations have been found in human tumor genomes, and it is suggested that some of them may alter affinity for KEA...
Main Authors: | Sara Matić, Ana Tomašić Paić, Sandra Sobočanec, Marija Pinterić, Goran Pipalović, Monika Martinčić, Mihaela Matovina, Sanja Tomić |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/4/1994 |
Similar Items
-
Identification of SH2 Domain-Containing Protein 3C as a Novel, Putative Interactor of Dipeptidyl Peptidase 3
by: Mihaela Matovina, et al.
Published: (2023-09-01) -
Modulation of NRF2/KEAP1 Signaling in Preeclampsia
by: Giovanni Tossetta, et al.
Published: (2023-06-01) -
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
by: Chenkai Cui, et al.
Published: (2022-09-01) -
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
by: Simone Adinolfi, et al.
Published: (2023-07-01) -
The KEAP1–NRF2 System in Cancer
by: Keiko Taguchi, et al.
Published: (2017-05-01)